Results 201 to 210 of about 198,632 (298)

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

Regulation of mild moxibustion on non-neuronal cholinergic system in ulcerative colitis rats. [PDF]

J Tradit Chin Med
Guangbin P, Han LI, Lu Z, Qin QI, Shiyu Z, Linshan Z, Yaying L, Zhe MA, Luyi WU, Yan H, Huangan WU.   +10 more
europepmc   +1 more source

Structural connections between the noradrenergic and cholinergic system shape the dynamics of functional brain networks. [PDF]

Neuroimage, 2022
Taylor NL, D'Souza A, Munn BR, Lv J, Zaborszky L, Müller EJ, Wainstein G, Calamante F, Shine JM.   +8 more
europepmc   +1 more source

Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III

Developmental Medicine &Child Neurology, EarlyView.
In this study, we followed a group of children 2 to 6 years old with spastic cerebral palsy functioning in GMFCS levels I–III, over 3 years. Sixty‐five received BoNT‐A and 59 did not. Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion. Daily step counts, favouring the BoNT‐
Darcy Fehlings, Emma Bohn, Lauren Switzer, Charles H. Goldsmith, Unni Narayanan, Peter L. Rosenbaum, F. Virginia Wright, Gary Foster, CP‐BoNT‐A Study Group, Timothy Carey, Mark Mason, Ronit Mesterman   +11 more
wiley   +1 more source

Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease. [PDF]

J Neurochem
Witzig V, Pjontek R, Tan SKH, Schulz JB, Holtbernd F.   +4 more
europepmc   +1 more source

Effect of the cholinergic system of the lateral periaqueductal gray (lPAG) on blood pressure and heart rate in normal and hydralazine hypotensive rats. [PDF]

Iran J Basic Med Sci, 2023
Ghorbani A, Mohebbati R, Rahimi A, Alikhani V, Shafei MN.   +4 more
europepmc   +1 more source

Respiratory dysfunction and fatal apnea during pilocarpine‐induced status epilepticus

Epilepsia, EarlyView.
Abstract Objective Status epilepticus (SE) is second only to sudden unexpected death in epilepsy as a cause of seizure‐related mortality. The progression of respiratory dysfunction during experimental SE remains poorly characterized. We investigated how pilocarpine‐induced SE affects respiration in mice.
Chengsan Sun, Rachel Spera, John M. Williamson, Suchitra Joshi, Bhavya Guduru, Harini Ganabady, Jaideep Kapur   +6 more
wiley   +1 more source

Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease. [PDF]

Neurobiol Dis
Crockett RA, Casselton C, Howard TM, Wilkins KB, Seo G, Brontë-Stewart HM, Alzheimer's Disease Neuroimaging Initiative (ADNI) database.   +6 more
europepmc   +1 more source

Non-neuronal cholinergic system delays cardiac remodelling in type 1 diabetes.

Heliyon, 2023
Munasinghe PE, Saw EL, Reily-Bell M, Tonkin D, Kakinuma Y, Fronius M, Katare R.   +6 more
europepmc   +1 more source

Participation of the Cholinergic System in the Development of Polycystic Ovary Syndrome. [PDF]

Molecules, 2021
Linares R, Acuña XN, Rosas G, Vieyra E, Ramírez DA, Chaparro A, Espinoza JA, Domínguez R, Morales-Ledesma L.   +8 more
europepmc   +1 more source